Analysis PATH High Conviction Pick Network Effects result
NYQ Β· Technology Β· Software - Infrastructure
$14.60
-0.06 (-0.44%)
PATH Interactive Price Chart & Trading Signals
PATH Stock Snapshot β Valuation, Risk & Technical Signals
PATH Key Fundamentals, Analyst Targets & Company Profile
Key Financial Ratios
Market Cap
$7.61B
P/E Ratio
21.78
Forward P/E
15.85
PEG Ratio
0.54
P/B Ratio
3.90
EPS
$0.67
Dividend Yield
β
52W Range
$9.20 β $19.84
Beta
1.02
Volume
33.2M
ROE
20.0%
Profit Margin
21.0%
Revenue Growth
13.4%
Gross Margin
82.6%
EV/EBITDA
34.86
Analyst Target
$16.85
The trailing price-to-earnings ratio stands at 21.8x. Forward P/E of 15.8x implies earnings expansion expected. Price-to-book is 3.90x. EV/EBITDA sits at 34.86x. Market capitalization is $7.61B. Revenue is growing at 13.4% on a trailing basis. Earnings are expanding at 2280.8%. Profit margins are 21.0%. Return on equity is 20.0%. Beta of 1.02 indicates market-average volatility.
Analyst Consensus
Recommendation
Hold
Low Target
$10.98
Mean Target
$16.85
High Target
$23.00
Based on 17 analysts
About PATH
UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. It offers the UiPath platform, an integrated enterprise software platform that enables AI agents, robots, people, and models to work together in coordinated workflows. The company's UiPath platform includes the UiPath Maestro process orchestration and process intelligence; UiPath agent builder; RPA and API automation; UiPath intelligent xtraction and processing; UiPath test cloud for testing and quality assurance; UiPath packaged and prebuilt agentic solutions; and centralized governance capabilities that apply across automations, AI agents, and manual tasks. It serves the financial services, healthcare, manufacturing, retail, and public sectors. The company was founded in 2005 and is headquartered in New York, New York.
PATH Deep Dive Analysis
Bottom Line
Verdict
OvervaluedBest for
Quality-focused portfoliosWatch out for
Premium valuationData confidence
HighUiPath, Inc. (PATH) trades above our multi-model fair value estimate of $9.61 by approximately 34.2%. Trailing P/E: 21.8x. Profitability signals include profit margin of 21.0% and return on equity of 20.0%. Recent growth metrics show revenue growth of 13.4% and earnings growth of 2280.8%. Risk profile: beta of 1.02. Consensus: hold.
PATH Deep Dive Analysis
Valuation
Overvalued
P/E 21.8x
Price is above what fundamentals suggest.
Growth
Expanding
Rev 13.4%
Revenue is outpacing the market.
Valuation Snapshot
UiPath, Inc. (PATH) trades above our multi-model fair value estimate of $9.61 by approximately 34.2%. The trailing price-to-earnings ratio stands at 21.8x. Forward P/E of 15.8x suggests earnings compression ahead. Price-to-sales is 4.4x. Price-to-book is 3.9x. EV/EBITDA sits at 34.9x. Market capitalization is $7.61B.
Why it matters: Paying a premium works only if the company keeps growing faster than expected.
Growth & Profitability
Revenue is growing at 13.4% on a trailing basis. Earnings are expanding at 2280.8%. Profit margins are 21.0%. Return on equity is 20.0%. Return on assets is 3.7%.
Why it matters: Growing revenue with healthy margins usually means the business is gaining market share or pricing power.
Risk Profile
Beta of 1.02 indicates market-average volatility. Net debt position is $-1204230016.00.
Why it matters: Lower risk means steadier returns, but often with less upside in bull markets.
Analyst Context
Analyst consensus target of $16.85 implies 15.5% upside. Target range spans $10.98 to $23.00. 17 analysts cover the stock. Consensus recommendation: hold.
Why it matters: Analyst targets reflect what professionals expect over 12 months. A wide gap between price and target can mean the market disagrees with the consensus.
Investor Fit
Strong profitability metrics may appeal to quality-focused portfolios.
Takeaway: Match the stock's risk-reward profile with your own goals and time horizon. No single metric tells the whole story.
Data Methodology & Sources
Market Data (Facts)
- Price, volume, market cap: Yahoo Finance (delayed ~5 min)
- P/E, EPS, revenue, debt: Yahoo Finance fundamentals
- Analyst targets: Yahoo Finance consensus (may lag)
- Insider trades: SEC EDGAR Form 4 filings
QuantSoar Model (Derived)
- Fair Value: 7-model consensus (DCF, Graham, P/E, P/S, DDM, EV/EBITDA, Div Yield) β trimmed inverse-variance weighted
- Margin of Safety = (Fair Value β Live Price) / Live Price Γ 100
- Composite Score: 40% Value + 30% Momentum + 30% Risk
- Verdict Gauge: Base 50 + Valuation(Β±25) + Whale(Β±10) + Macro(Β±10) + Technical(Β±10). Analyst consensus shown separately.
Model outputs are estimates based on available data and are not investment advice. Cross-check with primary sources before making investment decisions.
PATH Overvalued
UiPath, Inc. (PATH) trades above our multi-model fair value estimate of $9.61 by approximately 34.2%.
Frequently Asked Questions
ValuationIs PATH stock overvalued right now?
ValuationWhat is PATH fair value based on current fundamentals?
RiskHow risky is PATH compared with other stocks?
GrowthIs PATH still growing?
AnalystWhat do analysts think about PATH?
CatalystWhat could change the investment case for PATH?
Related Stocks
About the Author
Phasakorn Traklang (Peach) β Founder
Phasakorn Traklang (Peach) is the founder of QuantSoar, bringing expertise in SEO, web development, and technical analytics to build an AI-powered investment platform accessible to retail investors worldwide.
Connect on LinkedInInvestment Disclaimer: QuantSoar is for informational purposes only. We do not provide personalized investment advice. Always conduct your own research or consult a financial advisor. SEC
Data: Yahoo Finance / SEC EDGAR / Alpha Vantage / Finnhub. AI outputs verified against source data.